Related Experiment Video
Updated: Aug 16, 2026

Microwave-driven Synthesis of Iron Oxide Nanoparticles for Fast Detection of Atherosclerosis
Published on: March 22, 2016
[Atherosclerosis imaging to assess plaque progression]
1Section of Cardiology, Department of Medicine, Tulane University School of Medicine, 1430 Tulane Avenue, SL48, New Orleans, LA 70112-2699, USA. praggi@tulane.edu
Insights
Tracking atherosclerotic plaque progression aids cardiovascular risk prediction. Noninvasive imaging offers potential for earlier detection and efficient clinical trials, reducing healthcare costs.
Area of Science:
- Cardiology
- Medical Imaging
- Preventive Medicine
Background:
- Cardiovascular disease is a leading cause of death globally.
- Monitoring atherosclerotic plaque progression is crucial for predicting individual patient risk.
- Quantitative coronary angiography has been used to assess disease progression and outcomes.
Purpose of the Study:
- To explore the role of noninvasive imaging in detecting preclinical atherosclerotic plaque.
- To evaluate the effectiveness of preventive therapies using sequential imaging.
- To assess the potential of imaging tools in clinical trials for atherosclerosis.
Main Methods:
- Review of quantitative coronary angiography for plaque assessment.
- Focus on development of noninvasive imaging modalities.
- Utilizing sequential imaging for evaluating therapeutic interventions.
Main Results:
- Quantitative coronary angiography demonstrated plaque regression is linked to reduced adverse cardiovascular events.
- Emerging noninvasive techniques aim for early plaque detection.
- Noninvasive imaging can serve as intermediate endpoints in clinical trials.
Conclusions:
- Noninvasive imaging of atherosclerotic plaque is a promising area for cardiovascular risk assessment.
- These techniques may streamline clinical trials for atherosclerosis treatments.
- Successful implementation could lead to significant cost savings in healthcare.
Abstract:
Cardiovascular disease is the first cause of morbidity and mortality for both men and women in developed countries. Tracking the progression of the atherosclerotic plaque appears to be an effective way to predict modification of risk in individual patients. Quantitative coronary angiography was initially proposed as a method of choice to assess coronary disease progression. With this methodology it was possible to demonstrate a strong association of plaque regression with reduction in adverse cardiovascular outcomes. More recently, the focus of research has turned to the development of noninvasive modalities to image the atherosclerotic plaque in its preclinical stages and to evaluate the effectiveness of preventive therapies with sequential imaging. The ease of performance of these tests enabled their use as intermediate endpoints in clinical trials to test new strategies to treat atherosclerosis. If proven successful, these imaging tools may allow a reduction in size and duration of clinical trials with a substantial cost benefit for society.
Related Concept Videos
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis I: Introduction
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Imaging Studies for Cardiovascular System V: CT
